title: Normal expression of the Fanconi anemia proteins FAA and FAC and sensitivity to mitomycin C in two patients with Seckel syndrome.
abstract: Seckel syndrome is a rare autosomal recessive disorder. The classical presentation includes pre- and postnatal growth deficiency, mental retardation, and characteristic facial appearance. There have been several reports of associated hematological abnormalities and chromosomal breakage, findings suggestive of Fanconi anemia (FA). We tested for these findings in two Arabic patients with this syndrome. We compared the growth profile of lymphoblastoid cells from our patients and their parents with the FA group A cell line HSC72 in the presence and absence of mitomycin C (MMC). By Western analysis, we also determined the expression of FAA and FAC, two FA disease gene products that together account for approximately 80% of FA. Unlike HSC72 cells, cells from the patients were resistant to MMC, and both FAA and FAC proteins were expressed at similar levels in all cell lines. There is an increasing recognition of clinical variability and perhaps genetic heterogeneity in Seckel syndrome. Our results demonstrate that cross-link sensitivity comparable to FA is not a uniform finding in patients with Seckel syndrome.
authors.affiliation: Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
authors.forename: F
authors.initials: F
authors.lastname: Abou-Zahr
authors.forename: B
authors.initials: B
authors.lastname: Bejjani
authors.forename: F A
authors.initials: FA
authors.lastname: Kruyt
authors.forename: R
authors.initials: R
authors.lastname: Kurg
authors.forename: C
authors.initials: C
authors.lastname: Bacino
authors.forename: S K
authors.initials: SK
authors.lastname: Shapira
authors.forename: H
authors.initials: H
authors.lastname: Youssoufian
mesh_terms: D000015:Abnormalities, Multiple / Q000378:metabolism*; D015153:Blotting, Western; D018797:Cell Cycle Proteins; D002648:Child; D002675:Child, Preschool; D004268:DNA-Binding Proteins; D004305:Dose-Response Relationship, Drug; D005199:Fanconi Anemia / Q000235:genetics* / Q000378:metabolism*; D051856:Fanconi Anemia Complementation Group Proteins; D005260:Female; D006130:Growth Disorders / Q000378:metabolism; D006801:Humans; D008607:Intellectual Disability / Q000378:metabolism; D008297:Male; D016685:Mitomycin / Q000494:pharmacology*; D009687:Nuclear Proteins; D011506:Proteins / Q000378:metabolism*; D013577:Syndrome
chemical_list: D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D051856:Fanconi Anemia Complementation Group Proteins; D009687:Nuclear Proteins; D011506:Proteins; D016685:Mitomycin